935 related articles for article (PubMed ID: 19208514)
1. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of liver reserve function by ICGR15 detection before hepatectomy for hepatocellular carcinoma].
Lao XM; Zhang YQ; Guan YX; Guo RP; Lin XJ; Yuan YF; Li JQ; Li GH
Ai Zheng; 2004 Oct; 23(10):1213-7. PubMed ID: 15473939
[TBL] [Abstract][Full Text] [Related]
3. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis.
Zipprich A; Kuss O; Rogowski S; Kleber G; Lotterer E; Seufferlein T; Fleig WE; Dollinger MM
Gut; 2010 Jul; 59(7):963-8. PubMed ID: 20581243
[TBL] [Abstract][Full Text] [Related]
4. Hepatic parenchymal cell volume and the indocyanine green tolerance test.
Hashimoto M; Watanabe G
J Surg Res; 2000 Aug; 92(2):222-7. PubMed ID: 10896825
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis.
Stauber RE; Wagner D; Stadlbauer V; Palma S; Gurakuqi G; Kniepeiss D; Iberer F; Smolle KH; Haas J; Trauner M
Liver Int; 2009 Nov; 29(10):1516-20. PubMed ID: 19732329
[TBL] [Abstract][Full Text] [Related]
6. ICG pulse spectrophotometry for perioperative liver function in hepatectomy.
Okochi O; Kaneko T; Sugimoto H; Inoue S; Takeda S; Nakao A
J Surg Res; 2002 Mar; 103(1):109-13. PubMed ID: 11855925
[TBL] [Abstract][Full Text] [Related]
7. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.
Farnsworth N; Fagan SP; Berger DH; Awad SS
Am J Surg; 2004 Nov; 188(5):580-3. PubMed ID: 15546574
[TBL] [Abstract][Full Text] [Related]
8. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
Mun BS; Ahn HS; Ahn DS; Lee SO
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
Cheng XP; Zhao J; Chen Y; Meng FK; Xu B; Yu HW; Meng QH; Liu YM; Zhang SB; Meng S; Zhang JY; Zhang JY; Duan ZP; Zheng SJ
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness comparison of indocyanine green retention test with the cirrhotic severity scoring in evaluating the pathological severity of liver cirrhosis in patients with hepatocellular carcinoma and Child-Pugh grade A liver function.
Gu J; Zhang E; Liang B; Zhang Z; Chen X; Huang Z
World J Surg Oncol; 2020 Apr; 18(1):79. PubMed ID: 32326968
[TBL] [Abstract][Full Text] [Related]
11. [Prediction of perioperative mortality in patients with advanced liver disease and abdominal surgery by the use of different scoring systems and tests].
Hofmann WP; Rädle J; Moench C; Bechstein W; Zeuzem S
Z Gastroenterol; 2008 Nov; 46(11):1283-9. PubMed ID: 19012201
[TBL] [Abstract][Full Text] [Related]
12. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients.
Ecochard M; Boillot O; Guillaud O; Roman S; Adham M; Mion F; Dumortier J
Clin Transplant; 2011; 25(5):755-65. PubMed ID: 21158918
[TBL] [Abstract][Full Text] [Related]
13. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
[TBL] [Abstract][Full Text] [Related]
14. Preoperative assessment of liver function.
Schneider PD
Surg Clin North Am; 2004 Apr; 84(2):355-73. PubMed ID: 15062650
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests.
Forestier J; Dumortier J; Guillaud O; Ecochard M; Roman S; Boillot O; Lutringer D; Scoazec JY; Subtil F; Mion F
Eur J Gastroenterol Hepatol; 2010 May; 22(5):532-40. PubMed ID: 20164779
[TBL] [Abstract][Full Text] [Related]
16. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
Teh SH; Sheppard BC; Schwartz J; Orloff SL
Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
[TBL] [Abstract][Full Text] [Related]
18. Indocyanine green clearance test (using spectrophotometry) and its correlation with model for end stage liver disease (MELD) score in Indian patients with cirrhosis of liver.
Gupta S; Chawla Y; Kaur J; Saxena R; Duseja A; Dhiman RK; Choudhary NS
Trop Gastroenterol; 2012; 33(2):129-34. PubMed ID: 23025060
[TBL] [Abstract][Full Text] [Related]
19. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.
Schepke M; Roth F; Fimmers R; Brensing KA; Sudhop T; Schild HH; Sauerbruch T
Am J Gastroenterol; 2003 May; 98(5):1167-74. PubMed ID: 12809844
[TBL] [Abstract][Full Text] [Related]
20. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
